{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:08:33Z","timestamp":1788217713042,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10529-025-03604-5","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T14:33:49Z","timestamp":1749911629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery of novel compound IGYZT01060 for inhibition of IRAK-4 enzyme for the treatment of sepsis"],"prefix":"10.1007","volume":"47","author":[{"given":"Deepali","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavleen K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adinarayana Reddy","family":"Yerrapureddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8577-2143","authenticated-orcid":false,"given":"Sampath Kumar","family":"Nune Satya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"issue":"1","key":"3604_CR1","doi-asserted-by":"publisher","first-page":"13374","DOI":"10.1038\/s41598-021-92669-0","volume":"11","author":"NB AbdAllah","year":"2021","unstructured":"AbdAllah NB, Toraih EA, Al Ageeli E et al (2021) MYD88, NFKB1, and IL6 transcripts overexpression are associated with poor outcomes and short survival in neonatal sepsis. Sci Rep 11(1):13374. https:\/\/doi.org\/10.1038\/s41598-021-92669-0","journal-title":"Sci Rep"},{"issue":"12","key":"3604_CR2","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1038\/s41591-023-02635-7","volume":"29","author":"L Ackerman","year":"2023","unstructured":"Ackerman L, Acloque G, Bacchelli S et al (2023) IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial. Nat Med 29(12):3127\u20133136. https:\/\/doi.org\/10.1038\/s41591-023-02635-7","journal-title":"Nat Med"},{"key":"3604_CR3","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.2147\/DDDT.S307113","volume":"15","author":"SS Alghamdi","year":"2021","unstructured":"Alghamdi SS, Suliman RS, Almutairi K et al (2021) Imidazole as a promising medicinal scaffold: current status and future direction. Drug Des Dev Ther 15:3289\u20133312. https:\/\/doi.org\/10.2147\/DDDT.S307113","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"3604_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","volume":"21","author":"OA Almazroo","year":"2017","unstructured":"Almazroo OA, Miah MK, Venkataramanan R (2017) Drug metabolism in the liver. Clin Liver Dis 21(1):1\u201320. https:\/\/doi.org\/10.1016\/j.cld.2016.08.001","journal-title":"Clin Liver Dis"},{"issue":"13","key":"3604_CR5","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1016\/j.bmc.2006.02.045","volume":"14","author":"AGE Amr","year":"2006","unstructured":"Amr AGE, Abdulla MM (2006) Anti-inflammatory profile of some synthesized heterocyclic pyridone and pyridine derivatives fused with steroidal structure. Bioorg Med Chem 14(13):4341\u20134352. https:\/\/doi.org\/10.1016\/j.bmc.2006.02.045","journal-title":"Bioorg Med Chem"},{"key":"3604_CR6","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s12010-009-8689-6","volume":"160","author":"S Asha","year":"2010","unstructured":"Asha S, Vidyavathi M (2010) Role of human liver microsomes in in vitro metabolism of drugs\u2014a review. Appl Biochem Biotechnol 160:1699\u20131722. https:\/\/doi.org\/10.1007\/s12010-009-8689-6","journal-title":"Appl Biochem Biotechnol"},{"key":"3604_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1743-7075-5-27","volume":"5","author":"Z Bibi","year":"2008","unstructured":"Bibi Z (2008) Role of cytochrome P450 in drug interactions. Nutr Metab 5:27. https:\/\/doi.org\/10.1186\/1743-7075-5-27","journal-title":"Nutr Metab"},{"issue":"2","key":"3604_CR8","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1021\/acs.jmedchem.3c01714","volume":"67","author":"U Bothe","year":"2024","unstructured":"Bothe U, G\u00fcnther J, Nubbemeyer R et al (2024) Discovery of IRAK4 inhibitors BAY1834845 (Zabedosertib) and BAY1830839. J Med Chem 67(2):1225\u20131242. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01714","journal-title":"J Med Chem"},{"issue":"8","key":"3604_CR9","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1111\/bcp.14735","volume":"87","author":"CD Bruno","year":"2021","unstructured":"Bruno CD, Harmatz JS, Duan SX et al (2021) Effect of lipophilicity on drug distribution and elimination: influence of obesity. Br J Clin Pharmacol 87(8):3197\u20133205. https:\/\/doi.org\/10.1111\/bcp.14735","journal-title":"Br J Clin Pharmacol"},{"issue":"13","key":"3604_CR10","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.1021\/acs.jmedchem.9b00439","volume":"62","author":"MC Bryan","year":"2019","unstructured":"Bryan MC, Drobnick J, Gobbi A et al (2019) Development of potent and selective pyrazolopyrimidine IRAK4 inhibitors. J Med Chem 62(13):6223\u20136240. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00439","journal-title":"J Med Chem"},{"issue":"8","key":"3604_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/pharmaceutics13081208","volume":"13","author":"B Charlier","year":"2021","unstructured":"Charlier B, Coglianese A, De Rosa F et al (2021) The effect of plasma protein binding on the therapeutic monitoring of antiseizure medications. Pharmaceutics 13(8):1208. https:\/\/doi.org\/10.3390\/pharmaceutics13081208","journal-title":"Pharmaceutics"},{"key":"3604_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.666725","volume":"12","author":"RF Costa","year":"2021","unstructured":"Costa RF, Turones LC, Cavalcante KV et al (2021) Heterocyclic compounds: pharmacology of pyrazole analogs from rational structural considerations. Front Pharmacol 12:666725. https:\/\/doi.org\/10.3389\/fphar.2021.666725","journal-title":"Front Pharmacol"},{"key":"3604_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2269-7_19","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Methods Mol Biol. https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_19","journal-title":"Methods Mol Biol"},{"issue":"24","key":"3604_CR14","doi-asserted-by":"publisher","first-page":"15385","DOI":"10.1039\/D2RA01571D","volume":"12","author":"S De","year":"2022","unstructured":"De S, Kumar AS, Shah SK et al (2022) Pyridine: the scaffolds with significant clinical diversity. RSC Adv 12(24):15385\u201315406. https:\/\/doi.org\/10.1039\/D2RA01571D","journal-title":"RSC Adv"},{"issue":"1","key":"3604_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/imr.12499","volume":"274","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA (2016) The immune system\u2019s role in sepsis progression, resolution, and long-term outcome. Immunol Rev 274(1):330\u2013353. https:\/\/doi.org\/10.1111\/imr.12499","journal-title":"Immunol Rev"},{"issue":"2","key":"3604_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1378\/chest.118.2.503","volume":"118","author":"CA Dinarello","year":"2000","unstructured":"Dinarello CA (2000) Proinflammatory cytokines. Chest 118(2):503\u2013508. https:\/\/doi.org\/10.1378\/chest.118.2.503","journal-title":"Chest"},{"issue":"24","key":"3604_CR17","doi-asserted-by":"publisher","first-page":"18276","DOI":"10.1074\/jbc.M109.098137","volume":"285","author":"A Dunne","year":"2010","unstructured":"Dunne A, Carpenter S, Brikos C et al (2010) IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal). J Biol Chem 285(24):18276\u201318282. https:\/\/doi.org\/10.1074\/jbc.M109.098137","journal-title":"J Biol Chem"},{"key":"3604_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127925","author":"J Eppensteiner","year":"2019","unstructured":"Eppensteiner J, Kwun J, Scheuermann U et al (2019) Damage- and pathogen-associated molecular patterns play differential roles in late mortality after critical illness. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.127925","journal-title":"JCI Insight"},{"issue":"12","key":"3604_CR19","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1016\/j.apsb.2024.09.008","volume":"14","author":"Y Feng","year":"2024","unstructured":"Feng Y, Chen C, Shao A et al (2024) Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer. Acta Pharm Sin B 14(12):5091\u20135105. https:\/\/doi.org\/10.1016\/j.apsb.2024.09.008","journal-title":"Acta Pharm Sin B"},{"key":"3604_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku293","author":"D Gfeller","year":"2014","unstructured":"Gfeller D, Grosdidier A, Wirth M et al (2014) SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gku293","journal-title":"Nucleic Acids Res"},{"key":"3604_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-019-0215-7","volume":"19","author":"T Gong","year":"2019","unstructured":"Gong T, Liu L, Jiang W, Zhou R (2019) DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol 19:1\u201318. https:\/\/doi.org\/10.1038\/s41577-019-0215-7","journal-title":"Nat Rev Immunol"},{"key":"3604_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.33263\/BRIAC134.301","volume":"13","author":"RF Hassan","year":"2023","unstructured":"Hassan RF, Abdel-Hakeem MS, Aboulwafa MM et al (2023) Etanercept and infliximab, two tumor necrosis factor-\u03b1 (TNF-\u03b1) inhibitors with different action profiles: an in vitro and in vivo study in the context of reviewed therapeutic applications. Biointerface Res Appl Chem 13:4. https:\/\/doi.org\/10.33263\/BRIAC134.301","journal-title":"Biointerface Res Appl Chem"},{"key":"3604_CR23","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM et al (2016) Sepsis and septic shock. Nat Rev Dis Primers 2:16045. https:\/\/doi.org\/10.1038\/nrdp.2016.45","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"3604_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13771","volume":"17","author":"SJ Jodl","year":"2024","unstructured":"Jodl SJ, Ten Voorde W, Klein S et al (2024) The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers. Clin Transl Sci 17(3):e13771. https:\/\/doi.org\/10.1111\/cts.13771","journal-title":"Clin Transl Sci"},{"issue":"23","key":"3604_CR25","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.3390\/ijms20236008","volume":"20","author":"S Kany","year":"2019","unstructured":"Kany S, Vollrath JT, Relja B (2019) Cytokines in inflammatory disease. Int J Mol Sci 20(23):6008. https:\/\/doi.org\/10.3390\/ijms20236008","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3604_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai T, Akira S (2007) Signaling to NF-kB by Toll-like receptors. Trends Mol Med 13(11):461. https:\/\/doi.org\/10.1016\/j.molmed.2007.09.002","journal-title":"Trends Mol Med"},{"key":"3604_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/antibiotics13010046","volume":"13","author":"NR Kumar","year":"2024","unstructured":"Kumar NR, Balraj TA, Kempegowda SN et al (2024) Multidrug-resistant sepsis: a critical healthcare challenge. Antibiotics 13:46. https:\/\/doi.org\/10.3390\/antibiotics13010046","journal-title":"Antibiotics"},{"key":"3604_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658896","volume":"12","author":"A Lange","year":"2021","unstructured":"Lange A, Lange J, Jasku\u0142a E (2021) Cytokine overproduction and immune system dysregulation in alloHSCT and COVID-19 patients. Front Immunol 12:658896. https:\/\/doi.org\/10.3389\/fimmu.2021.658896","journal-title":"Front Immunol"},{"issue":"4","key":"3604_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/sur.2016.021","volume":"17","author":"AJ Lewis","year":"2016","unstructured":"Lewis AJ, Seymour CW, Rosengart MR (2016) Current murine models of sepsis. Surg Infect (Larchmt) 17(4):385\u2013393. https:\/\/doi.org\/10.1089\/sur.2016.021","journal-title":"Surg Infect (Larchmt)"},{"issue":"3","key":"3604_CR30","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/eji.200838161","volume":"38","author":"X Li","year":"2008","unstructured":"Li X (2008) IRAK4 in TLR\/IL-1R signaling: possible clinical applications. Eur J Immunol 38(3):614\u2013618. https:\/\/doi.org\/10.1002\/eji.200838161","journal-title":"Eur J Immunol"},{"key":"3604_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113459","volume":"153","author":"Q Li","year":"2022","unstructured":"Li Q, Li R, Yin H et al (2022) Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome. Biomed Pharmacother 153:113459. https:\/\/doi.org\/10.1016\/j.biopha.2022.113459","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3604_CR32","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1038\/s41467-024-49540-2","volume":"15","author":"H Li","year":"2024","unstructured":"Li H, Li Z, Lin C et al (2024) Precise recognition of benzonitrile derivatives with supramolecular macrocycle of phosphorylated cavitand by co-crystallization method. Nat Commun 15(1):5315. https:\/\/doi.org\/10.1038\/s41467-024-49540-2","journal-title":"Nat Commun"},{"key":"3604_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21767\/2576-3938.100019","volume":"2","author":"B Liccardo","year":"2018","unstructured":"Liccardo B, Formisano T, D\u2019Andrea A et al (2018) Diagnosis, management and treatment of septic shock from early diagnosis to infection focus control. J Emerg Intern Med 2:19. https:\/\/doi.org\/10.21767\/2576-3938.100019","journal-title":"J Emerg Intern Med"},{"issue":"1","key":"3604_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/jpbs.JPBS_32_21","volume":"13","author":"A Malik","year":"2021","unstructured":"Malik A, Mishra R, Mazumder R et al (2021) Pathogenesis of septic shock and current therapeutic approaches. J Pharm Bioallied Sci 13(1):139\u2013145. https:\/\/doi.org\/10.4103\/jpbs.JPBS_32_21","journal-title":"J Pharm Bioallied Sci"},{"key":"3604_CR36","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/cdd.2015.176","volume":"23","author":"F Mart\u00edn-S\u00e1nchez","year":"2016","unstructured":"Mart\u00edn-S\u00e1nchez F, Diamond C, Zeitler M et al (2016) Inflammasome-dependent IL-1\u03b2 release depends upon membrane permeabilisation. Cell Death Differ 23:1219\u20131231. https:\/\/doi.org\/10.1038\/cdd.2015.176","journal-title":"Cell Death Differ"},{"issue":"8","key":"3604_CR37","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jics.2022.05.005","volume":"99","author":"A Mohanty","year":"2022","unstructured":"Mohanty A, Patra C, Sahu P et al (2022) Therapeutic potential of pyridine and its derivatives. J Indian Chem Soc 99(8):1545\u20131561. https:\/\/doi.org\/10.1016\/j.jics.2022.05.005","journal-title":"J Indian Chem Soc"},{"key":"3604_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000210","author":"MF Mostafa","year":"2020","unstructured":"Mostafa MF, Mahmud R, Sharaf MA et al (2020) Discovery of a novel pyridine-3-carboxamide derivative as a selective inhibitor of cyclin-dependent kinase 2. Arch Pharm. https:\/\/doi.org\/10.1002\/ardp.202000210","journal-title":"Arch Pharm"},{"issue":"1","key":"3604_CR44","doi-asserted-by":"publisher","first-page":"e1000","DOI":"10.1097\/CCE.0000000000001000","volume":"6","author":"T Pitre","year":"2024","unstructured":"Pitre T et al (2024) Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose\u2013response meta-analysis. Crit Care Explor 6(1):e1000. https:\/\/doi.org\/10.1097\/CCE.0000000000001000","journal-title":"Crit Care Explor"},{"issue":"12","key":"3604_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101870","volume":"31","author":"S Preeti","year":"2023","unstructured":"Preeti S, Sambhakar S, Saharan R et al (2023) Exploring lipids for their potential to improve bioavailability of lipophilic drug candidates: a review. Saudi Pharm J 31(12):101870. https:\/\/doi.org\/10.1016\/j.jsps.2023.101870","journal-title":"Saudi Pharm J"},{"key":"3604_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s40011-025-01691-y","author":"D Shrivastava","year":"2025","unstructured":"Shrivastava D, Panwar D, Gupta LK et al (2025) Septic shock inhibition by targeting IRAK-4. Proc Natl Acad Sci India B. https:\/\/doi.org\/10.1007\/s40011-025-01691-y","journal-title":"Proc Natl Acad Sci India B"},{"issue":"24","key":"3604_CR52","doi-asserted-by":"publisher","first-page":"8038","DOI":"10.3390\/molecules28248038","volume":"28","author":"M Stielow","year":"2023","unstructured":"Stielow M, Witczy\u0144ska A, Kubry\u0144 N et al (2023) The bioavailability of drugs\u2014the current state of knowledge. Molecules 28(24):8038. https:\/\/doi.org\/10.3390\/molecules28248038","journal-title":"Molecules"},{"issue":"10","key":"3604_CR57","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1039\/D1MD00131K","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Wang Y, Li X et al (2021) Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies. RSC Med Chem 12(10):1650\u20131671. https:\/\/doi.org\/10.1039\/D1MD00131K","journal-title":"RSC Med Chem"},{"key":"3604_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.880732","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Yao J, Wang L et al (2023) Role of the NLRP3 inflammasome in sepsis and its potential therapeutic targets. Front Immunol 14:880732. https:\/\/doi.org\/10.3389\/fimmu.2023.880732","journal-title":"Front Immunol"},{"issue":"12","key":"3604_CR55","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/art.41953","volume":"73","author":"A Winkler","year":"2021","unstructured":"Winkler A, Sun W, De S et al (2021) The interleukin-1 receptor-associated kinase 4 inhibitor PF-06650833 blocks inflammation in preclinical models of rheumatic disease and in humans enrolled in a randomized clinical trial. Arthritis Rheumatol 73(12):2206\u20132218. https:\/\/doi.org\/10.1002\/art.41953","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3604_CR60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/molecules28010022","volume":"28","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Lu H, Wei Y et al (2023) Discovery of novel pyrazole derivatives as potential anti-inflammatory agents through structure\u2013activity relationship studies. Molecules 28(1):22. https:\/\/doi.org\/10.3390\/molecules28010022","journal-title":"Molecules"},{"key":"3604_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov 6:36. https:\/\/doi.org\/10.1038\/s41421-020-0167-x","journal-title":"Cell Discov"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-025-03604-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-025-03604-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-025-03604-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:34:15Z","timestamp":1751002455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10529-025-03604-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3604"],"URL":"https:\/\/doi.org\/10.1007\/s10529-025-03604-5","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"62"}}